Is RSA Insurance Group plc A Recovery Buy For 2014?

RSA Insurance Group plc (LON:RSA) is down 27% in three months. Will 2014 see this battered insurance stock make a strong recovery?

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

2013 has been the year in which even the most hardened stock market bears have admitted that we’re in a five-year bull market — and it’s not over yet.

Although the FTSE 100 has slipped back from the five-year high of 6,875 it reached in May, it is still up 6.9% this year, and is 50% higher than it was five years ago.

Unfortunately, RSA Insurance Group (LSE: RSA) (NASDAQOTH: RSANY.US) hasn’t joined the rally, and a multitude of profit warnings and other problems have seen its share slump by 28% so far this year, leaving them 35% lower than they were five years ago.

Back to basics

Will RSA prove to be a recovery buy that outperforms the market in 2014? I suspect it’s too early to say, but one thing we can do today is to treat RSA’s falling share price as a potential buying opportunity, and take a look at its fundamentals, to see if they show any signs of offering investing value:

Ratio Value
Trailing twelve month P/E 8.8
Trailing dividend yield 6.9%
Net asset value per share 99p*
IGD surplus cover 1.5 x

* 92p exc. pension deficit.

On the face of it, these figures don’t necessarily seem too bad, but in reality, they’re not great. RSA’s second-half earnings are likely to fall, increasing its P/E, while a further dividend cut also seems likely, as RSA seeks to preserve capital to save its ‘A’ credit rating.

Similarly, although RSA’s shares currently trade at a discount to its book value of 99p per share, this has fallen from 107p at the end of last year, and excludes a 7p per share pension deficit. The firm’s IGD surplus cover — a measure of capital in excess of regulatory requirements — has also fallen this year, from 1.9 times at the end of 2012, to its current level of 1.5 times.

A troubled year ahead?

RSA’s latest update says that it is undertaking a full review of its business and expects to deliver ‘mid-single digit return on equity’ in 2013 — which by my reckoning equates to earnings per share of 6-7p.

The question is whether the firm’s profits can recover quickly in 2014. At the time of writing, analysts’ consensus forecasts have been downgraded for 2013, but remain fairly positive for next year:

2014 Forecasts Value
Price to earnings (P/E) 7.3
Dividend yield 7.1%
Earnings growth 59%
P/E  to earnings growth (PEG) 0.2

To be honest, I don’t think these figures are realistic; I expect to see a further round of downgraded forecasts in the next month or two and believe that a dividend cut is also likely.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Roland does not own shares in RSA Insurance Group.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »